QHM-2025-7390 PHD.IntegratedDiabetes/PLT

The public procurement process for the contract titled "QHM-2025-7390 PHD.IntegratedDiabetes/PLT," conducted by the NHS North East and North Cumbria Integrated Care Board, focuses on blood analysis services within the healthcare services industry. This service-oriented procurement falls under the jurisdiction of the Health Care Services (Provider Selection Regime) Regulations 2023 and is being carried out using a limited procurement method, indicating no prior publication of a call for competition. The procurement relates to services to be delivered across various UK regions, particularly starting from Sunderland.

The entire process was initiated in the context of a direct award due to the satisfactory performance of the existing provider. Key dates for this procurement include the contract award announcement on August 4, 2025, with the formal contract start date set for April 1, 2025, and ending on March 31, 2026. The contract value is recorded at £269,526.

This procurement presents significant opportunities for businesses involved in healthcare services, especially those that can demonstrate exceptional service delivery in the realm of blood analysis. Companies like Primary Healthcare Darlington Ltd, which is the identified supplier, exemplify the type of large-scale provider suitable for managing such contracts. Business expansion prospects are bolstered by contracts that target the healthcare industry's specialised segments, creating opportunities for growth within the service delivery and management ventures across the United Kingdom.

Companies with the capability to meet the stringent quality and cost standards as assessed by the NHS Integrated Care Board will thrive in this competitive landscape. Potential bidders are encouraged to focus on delivering high-quality services aligned with the board’s strategic healthcare objectives and service area needs.